Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
The purpose of this study is to investigate whether use of blood volume analysis in the diagnosis and treatment of heart failure patients leads to increased longevity, decreased hospitalization, and improved daily functioning and quality of life relative to clinical assessment alone.
Sponsor: Daxtor Corp. Principal Investigator: John Strobeck, MD Co-Investigators: Robin Giordano, NP, John Pantazopoulos, MD, Howard Goldschmidt, MD, Arvind Agarwal, MD, Navin Budhwani, MD, Michael Kesselbrenner, MD, Janet Strain, MD
For more information, please call 201-447-8453.
Treatment of Preserved Cardiac function heart failure with an Aldosterone anTagonist
The purpose of this study is to see if adding a drug called spironolactone to the current treatments for heart failure is able to safely improve heart failure.
Sponsor: National Heart, Lung, and Blood Institute (NHLBI), NIH/DHHS, United States Principal Investigator: Michael Kesselbrenner, MD Sub-Investigators: Robert Saporito, MD; Alan Simon, MD; Howard Goldschmidt, MD